EndpointsNews Features Dr. Lili Yang in their 2022 Women in Biopharma’22 Report

Over the past three years, Endpoints News has spotlighted 60 women who have blazed trails and supercharged R&D across the biopharma world. MIMG Faculty Dr. Lili Yang is one of the latest recipients to be honored on this list for 2022. This profile recognizes her accomplishment in biotech entrepreneurship. In particular, Yang’s recent biotech startup, Appia Bio, which is based on her research in UCLA MIMG labs.

For more information, please read the article: Special report 2022: Meet 20 women blazing trails in biopharma R&D